Deep Brain Stimulation Device Market Report 2026

Deep Brain Stimulation Device Market Overview

• Deep Brain Stimulation Device market size has reached to $1.7 billion in 2025 • Expected to grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 11.6% • Growth Driver: Increasing Disease Prevalence Surging Demand For Deep Brain Stimulation Devices • Market Trend: Innovative Advancements In Deep Brain Stimulation Devices • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Deep Brain Stimulation Device Market?

Deep brain stimulation devices are specialized medical instruments that deliver an electrical current directly to areas of the brain. These electrical impulses can also adjust for the chemical imbalances within the brain that cause various conditions. It is used to treat neuropsychological disorders. The main product type of deep brain stimulation devices are single-channel deep brain stimulators, and dual-channel deep brain stimulators. A single-channel deep brain stimulator refers to a medical device that delivers an electrical current directly to areas of the brain. The various applications include epilepsy, essential tremor, obsessive-compulsive disorder (OCD), depression, dystonia, Parkinson’s disease, pain management, and others and are used by hospitals, neurology clinics, ambulatory surgical centers, and research centers.

What Is The Deep Brain Stimulation Device Market Growth Forecast?

The deep brain stimulation device market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to growing focus on precision neuromodulation therapies, rising investments in neurotechnology research, expansion of indications beyond movement disorders, increasing adoption of remote programming capabilities, continuous innovation in implantable electronics. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising demand for personalized dbs programming, growing use of rechargeable implantable pulse generators, expansion of image-guided electrode placement techniques, enhanced focus on minimally invasive neurosurgical procedures.

Global Deep Brain Stimulation Device Market Segmentation

1) By Product Type: Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator 2) By Application: Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Dystonia, Parkinson’s Disease, Other Applications 3) By End User: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers Subsegments: 1) By Single-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories 2) By Dual-Channel Deep Brain Stimulator: Implantable Pulse Generators, Electrode Leads, Accessories

What Is The Driver Of The Deep Brain Stimulation Device Market?

The increasing prevalence of neurological diseases is expected to propel the growth of the deep brain stimulation device market going forward. Medical conditions affecting the central and peripheral nervous systems are known as neurological disorders. Deep brain stimulation devices are used to control abnormal brain activity and adjust the chemical imbalances within the brain that cause various conditions. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. As a result, the increasing prevalence of neurological disorders is propelling the growth of the deep brain stimulation device industry.

Key Players In The Global Deep Brain Stimulation Device Market

Major companies operating in the deep brain stimulation device market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova plc, Aleva Neurotherapeutics SA, Beijing PINS Medical Co. Ltd., SceneRay Corporation, MicroPort NeuroTech, Precisis AG, Neuralink Corporation, Sapiens Neuro, Functional Neuromodulation Ltd., Deep Brain Innovation LLC, Renishaw plc, NeuroOne Medical Technologies Corporation, CorTec GmbH, INBRAIN Neuroelectronics S.L., Synchron Inc., Rune Labs Inc., CereGate GmbH

Global Deep Brain Stimulation Device Market Trends and Insights

Major companies operating in the deep brain stimulation device market are developing technological advancements, such as connected care technology, to enhance patient care by enabling remote programming, improving communication between patients and healthcare providers, and optimizing treatment outcomes for individuals with movement disorders. Connected care technology refers to the integration of digital tools and platforms that facilitate continuous communication and data exchange between patients and healthcare providers, enhancing patient monitoring, treatment management, and overall healthcare delivery. For instance, in January 2024, Abbott Laboratories, a US-based healthcare and medical device company, received US Food and Drug Administration approval for the Liberta RC DBS system, the smallest rechargeable deep brain stimulation device for treating movement disorders. Key features of the Liberta RC DBS system include remote programming via the NeuroSphere Virtual Clinic, a requirement of only 10 recharges per year, and a compact design that is 31% smaller than competing devices. It also boasts a wireless charging system that can recharge the device every 37 days and offers customizable controls through an Abbott patient controller or compatible iOS devices.

What Are Latest Mergers And Acquisitions In The Deep Brain Stimulation Device Market?

In September 2023, Amber Therapeutics, a US-based healthcare technology company, acquired Bioinduction Limited for an undisclosed amount. With this acquisition, Amber Tx aims to enhance its technological capabilities and accelerate the development of its closed-loop neuromodulation therapy for mixed urinary incontinence. Bioinduction Limited is a UK-based healthcare technology company that specializes in providing a deep brain stimulation (DBS) device.

Regional Outlook

North America was the largest region in the deep brain stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global deep brain stimulation devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Deep Brain Stimulation Device Market?

The deep brain stimulation devices market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.